highperformr logo

Azevan Pharmaceuticals's Overview

Total employees5
HeadquartersBethlehem
Founded

Azevan Pharmaceuticals is a clinical-stage pharmaceutical company committed to developing new medicines for treating disorders of the central nervous system (CNS). Their research focuses on stress-related and neuropsychiatric conditions with significant unmet medical needs. Azevan's pipeline includes novel compounds targeting vasopressin 1a (V1a) receptors, such as SRX246, which has been investigated for conditions like intermittent explosive disorder (IED), post-traumatic stress disorder (PTSD), and other stress-related psychiatric disorders. The company aims to provide innovative therapeutic options that improve the lives of patients suffering from these challenging conditions.

Where is Azevan Pharmaceuticals's Headquarters?

HQ Function

The headquarters serves as the central hub for Azevan's research and development operations, clinical trial management, strategic planning, and corporate administration.

Notable Features:

Located within Ben Franklin TechVentures, an award-winning technology incubator/post-incubator, providing access to state-of-the-art facilities, lab space, and a collaborative environment conducive to biotech innovation.

Work Culture:

The work culture is likely focused on scientific rigor, innovation, and collaboration, driven by the mission to develop impactful CNS therapies. As a clinical-stage company, the environment is probably dynamic and results-oriented.

HQ Significance:

The Bethlehem headquarters is significant as it places Azevan within a supportive ecosystem for biotechnology startups and research, facilitating access to talent, resources, and potential partnerships in the Lehigh Valley.

Values Reflected in HQ: The choice of location reflects values of innovation, collaboration, and leveraging a supportive technological ecosystem to advance their scientific goals.

Location:

As a clinical-stage company, Azevan Pharmaceuticals' global presence is primarily related to its clinical trial activities. They may conduct trials at various sites internationally to ensure diverse patient populations and efficient recruitment for their CNS drug candidates. They might also collaborate with international research institutions or contract research organizations (CROs) to support their development programs.

Street Address:

1770 Bathgate Road, Suite 302

City:

Bethlehem

State/Province:

Pennsylvania

Country:

United States

Azevan Pharmaceuticals's Global Presence

Buying Intent Signals for Azevan Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Azevan Pharmaceuticals

As of April 2025, Azevan Pharmaceuticals' leadership includes:

Neal G. Simon, Ph.D. - President & Chief Executive Officer
Stephen M. Collins, M.D., Ph.D. - Chief Medical Officer
Larry Ereshefsky, Pharm.D. - Chief Scientific Officer, CNS Clinical & Translational Medicine
William K. Childers, Ph.D. - Head of Chemistry

Investors of Azevan Pharmaceuticals

Azevan Pharmaceuticals has been backed by several prominent investors over the years, including:

Melior Discovery
Ben Franklin Technology Partners of Northeastern Pennsylvania
Broad Street Angels
Delaware Crossing Investor Group
Keiretsu Forum Mid-Atlantic
National Institutes of Health (NIH) - primarily through grants for research

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major executive hires or exits have been publicly announced by Azevan Pharmaceuticals in the last 12 months. The leadership team appears to be stable based on available information.

Technology (Tech Stack) used by Azevan Pharmaceuticals

Discover the tools Azevan Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Azevan Pharmaceuticals Email Formats and Examples

Azevan Pharmaceuticals likely utilizes standard professional email formats. The most common format for companies of this nature is typically the first initial followed by the last name, or the full first name followed by the last name.

[first_initial][last]@azevan.com

Format

nsimon@azevan.com

Example

80%

Success rate

News and media

Azevan Pharmaceuticals NewsJune 28, 2023

Azevan Pharmaceuticals news title: Azevan Pharmaceuticals Announces Publication of Positive Phase 2 Study Results for SRX246 in Intermittent Explosive Disorder (IED) in the Journal of Clinical Psychiatry

Azevan Pharmaceuticals announced that positive results from its Phase 2 proof-of-concept study of SRX246 for the treatment of Intermittent Explosive Disorder (IED) have been published in The Journal of Clinical Psychiatry. The study demonstrated that SRX246 was well-tolerated and showed a statistically significant reduction in aggression compared to placebo....more

GlobeNewswireMarch 1, 2022

Azevan Pharmaceuticals news title: Azevan Pharmaceuticals’ SRX246 Receives FDA Fast Track Designation for the Treatment of Intermittent Explosive Disorder

Azevan Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SRX246 for the treatment of Intermittent Explosive Disorder (IED). This designation facilitates the development and expedites the review of drugs to treat serious conditions and fill an unmet medical need....more

Azevan Pharmaceuticals NewsNovember 10, 2021

Azevan Pharmaceuticals news title: Azevan Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of SRX246 in Adults with Intermittent Explosive Disorder

Azevan Pharmaceuticals announced positive topline results from its Phase 2 proof-of-concept study evaluating SRX246 for the treatment of Intermittent Explosive Disorder (IED) in adults. The study met its primary endpoint, showing a statistically significant reduction in aggression....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Azevan Pharmaceuticals, are just a search away.